SonoMotion secures a $1.75M SBIR FastTrack grant from the NIH for the development of Break Wave™.
SonoMotion receives a $350,000 grant from NASA and NSBRI to accelerate development of Break Wave™.
SonoMotion wins Runner-Up and $50,000 in the prestigious prime UC life science startup competition organized by the University of California and Johnson & Johnson.
Dr. Doug Corl joins SonoMotion as its Chief Technology Officer bringing over 35 years of experience in developing commercial ultrasound-based medical devices.
SonoMotion secures a $1.75M non-dilutive SBIR grant funding from the NIH for the development of Stone Clear™.
SonoMotion reaches agreement with the University of Washington for exclusive license to an extensive IP portfolio related to Break Wave™ and Stone Clear™.
Positive First-In-Man Stone Clear™ clinical trial results presented at the American Urological Association (AUA) meeting in New Orleans.
SonoMotion brings onboard Dr. Oren Levy as its Chief Executive Officer and Chairman of the Board.